ADAR1 Capital Management »

Inflarx Nv shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Inflarx Nv (IFRX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Inflarx Nv

Tip: Access up to 7 years of quarterly data

All positions including Inflarx Nv held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inflarx Nv by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $214k 160k 1.34

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Inflarx Nv

Suvretta Capital Management
683 Capital Management
RA Capital Management
Eversept Partners
Ikarian Capital
Raymond James Financial
Adage Capital Partners GP
Marshall Wace
Squarepoint Ops
Boothbay Fund Management
ADAR1 Capital Management
Citadel Advisors
Susquehanna International
Jane Street
Kestra Advisory Services

View all funds holding Inflarx Nv